Paper25035388
Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance.
Rabar S and 4 others. BMJ, 2014. Cited by 235 papers, by iCite.
Cite this record
ConductScience Library. Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance. Papers, record 25035388. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25035388
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiovascular Diseases | Major topic |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | Major topic |
| Lipids | Major topic |
| Risk Assessment | Major topic |
| Anion Exchange Resins | |
| Diabetes Complications | |
| Diet | |
| Fatty Acids, Omega-3 | |
| Fibric Acids | |
| Glomerular Filtration Rate | |
| Humans | |
| Hyperlipidemias | |
| Hypolipidemic Agents | |
| Nicotinic Acids | |
| Practice Guidelines as Topic | |
| Primary Prevention | |
| Renal Insufficiency, Chronic | |
| Secondary Prevention |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 25186969 | NICE must do better at summarising and communicating evidence on statins. | https://conductscience.org/library/papers/25186969 |
Source PubMed
Cited by121
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 235 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42432440 | Association Between Optimal Revascularization for Chronic Total Occlusion and Long-Term Outcomes in Patients With Heart Failure With or Without Type 2 Diabetes. | J Am Heart Assoc | 2026 | https://conductscience.org/library/papers/42432440 | PubMed |
| 42064873 | Clinical characteristics of patients with diabetic peripheral neuropathy: a retrospective descriptive study. | Front Clin Diabetes Healthc | 2026 | https://conductscience.org/library/papers/42064873 | PubMed |
| 42050529 | Synergistic effects of insulin resistance and revascularization completeness on prognosis in patients with coronary artery calcification. | Cardiovasc Diabetol | 2026 | https://conductscience.org/library/papers/42050529 | PubMed |
| 41987068 | Plasma homocysteine and cardiovascular outcomes in postmenopausal women with coronary heart disease: a retrospective cohort study. | BMC Cardiovasc Disord | 2026 | https://conductscience.org/library/papers/41987068 | PubMed |
| 41392353 | Combined clinical, metabolomic, and polygenic scores for cardiovascular risk prediction. | Eur Heart J | 2025 | https://conductscience.org/library/papers/41392353 | PubMed |
| 41238712 | The association between APOA1 levels and long-term outcomes in H-type hypertension with acute myocardial infarction patients: A retrospective cohort study. | J Hum Hypertens | 2026 | https://conductscience.org/library/papers/41238712 | PubMed |
| 40940402 | Serum lncRNA-ANRIL and creatinine clearance as cardiovascular risk factors in patients who underwent sleeve gastrectomy. | Sci Rep | 2025 | https://conductscience.org/library/papers/40940402 | PubMed |
| 40387056 | Prognostic impact of systemic inflammatory response index in patients with myocardial infarction with non-obstructive coronary arteries. | Chin Med J (Engl) | 2025 | https://conductscience.org/library/papers/40387056 | PubMed |
| 40303637 | The association between stress hyperglycemia ratio and 1-year outcomes in patients with acute myocardial infarction: a retrospective large sample cohort study. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/40303637 | PubMed |
| 40275234 | Reply to: What evidence is required to justify the NHS Health Check programme? | BMC Med | 2025 | https://conductscience.org/library/papers/40275234 | PubMed |
| 40102916 | Prognostic impact of prediabetes on long-term cardiovascular outcomes in patients under 35 with premature acute myocardial infarction. | Diabetol Metab Syndr | 2025 | https://conductscience.org/library/papers/40102916 | PubMed |
| 39534649 | Machine-learning-based prediction of cardiovascular events for hyperlipidemia population with lipid variability and remnant cholesterol as biomarkers. | Health Inf Sci Syst | 2024 | https://conductscience.org/library/papers/39534649 | PubMed |
| 39031184 | Effect of anti-diabetic agent on interstitial lung disease in patients with diabetes mellitus. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/39031184 | PubMed |
| 39030064 | Risk estimation for the primary prevention of cardiovascular disease: considerations for appropriate risk prediction model selection. | Lancet Glob Health | 2024 | https://conductscience.org/library/papers/39030064 | PubMed |
| 38948897 | The effect of fasting plasma glucose on in-hospital mortality after acute myocardial infarction in patients with and without diabetes: findings from a prospective, nationwide, and multicenter registry. | J Geriatr Cardiol | 2024 | https://conductscience.org/library/papers/38948897 | PubMed |
| 38654927 | Free triiodothyronine to free thyroxine ratio as a marker of poor prognosis in euthyroid patients with acute coronary syndrome and diabetes after percutaneous coronary intervention. | Front Endocrinol (Lausanne) | 2024 | https://conductscience.org/library/papers/38654927 | PubMed |
| 38572097 | Construction and characterization of a humanized SLCO1B1 rat model with its application in evaluating the uptake of different statins. | Acta Pharm Sin B | 2024 | https://conductscience.org/library/papers/38572097 | PubMed |
| 38219904 | Indian dyslipidaemia guidelines: Need of the hour. | Indian Heart J | 2024 | https://conductscience.org/library/papers/38219904 | PubMed |
| 38200427 | Determinants of poor glycaemic control and proteinuria in patients with type 2 diabetes: a retrospective analysis of general practice records in Ireland. | BMC Prim Care | 2024 | https://conductscience.org/library/papers/38200427 | PubMed |
| 37979723 | Management of triglycerides, non-high density lipoprotein cholesterol and high density lipoprotein cholesterol. | Indian Heart J | 2024 | https://conductscience.org/library/papers/37979723 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25035388
GET https://conductscience.org/api/papers/v1/25035388/cited_by?page=2